Clinical Trial Update: Etanercept Therapy for Sjogren's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating etanercept for Sjogren's syndrome has completed; the study was sponsored by the National Institute of Dental and Craniofacial Researc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED